82 related articles for article (PubMed ID: 12918109)
1. Expression of tumor related genes NGX6, NAG-7, BRD7 in gastric and colorectal cancer.
Zhang XM; Wang XY; Sheng SR; Wang JR; Li J
World J Gastroenterol; 2003 Aug; 9(8):1729-33. PubMed ID: 12918109
[TBL] [Abstract][Full Text] [Related]
2. LncRNA LENGA acts as a tumor suppressor in gastric cancer through BRD7/TP53 signaling.
Li S; Sun J; Ma J; Zhou C; Yang X; Zhang S; Huang L; Jia H; Shao Y; Zhang E; Zheng M; Zhao Q; Zang L
Cell Mol Life Sci; 2022 Dec; 80(1):5. PubMed ID: 36477655
[TBL] [Abstract][Full Text] [Related]
3. The phospholipase PNPLA7 functions as a positive indicator in human colorectal and gastric cancers.
Bai Y; Luo K; Xie W
Medicine (Baltimore); 2023 Oct; 102(42):e35279. PubMed ID: 37861523
[TBL] [Abstract][Full Text] [Related]
4. Identification of NOL8, a nucleolar protein containing an RNA recognition motif (RRM), which was overexpressed in diffuse-type gastric cancer.
Jinawath N; Furukawa Y; Nakamura Y
Cancer Sci; 2004 May; 95(5):430-5. PubMed ID: 15132771
[TBL] [Abstract][Full Text] [Related]
5. Editorial: Advances in the surgical management of gastric and colorectal cancers.
Parente P
Front Oncol; 2023; 13():1292465. PubMed ID: 38023202
[No Abstract] [Full Text] [Related]
6. BRD7 inhibits enhancer activity and expression of BIRC2 to suppress tumor growth and metastasis in nasopharyngeal carcinoma.
Li M; Wei Y; Liu Y; Wei J; Zhou X; Duan Y; Chen S; Xue C; Zhan Y; Zheng L; Deng H; Tang F; Fan S; Xiong W; Li G; Tan M; Zhou M
Cell Death Dis; 2023 Feb; 14(2):121. PubMed ID: 36788209
[TBL] [Abstract][Full Text] [Related]
7. Genetic and molecular biology of breast cancer among Iranian patients.
Moghbeli M
J Transl Med; 2019 Jul; 17(1):218. PubMed ID: 31286981
[TBL] [Abstract][Full Text] [Related]
8. The role of long noncoding RNA-LET in cell proliferation and invasion of nasopharyngeal carcinoma and its mechanism.
Chen L; Sun L; Dong L; Cui P; Xia Z; Li C; Zhu Y
Onco Targets Ther; 2017; 10():2769-2778. PubMed ID: 28615956
[TBL] [Abstract][Full Text] [Related]
9. Identification of skin-related lncRNAs as potential biomarkers that involved in Wnt pathways in keloids.
Sun XJ; Wang Q; Guo B; Liu XY; Wang B
Oncotarget; 2017 May; 8(21):34236-34244. PubMed ID: 28404955
[TBL] [Abstract][Full Text] [Related]
10. BRD7: a novel tumor suppressor gene in different cancers.
Yu X; Li Z; Shen J
Am J Transl Res; 2016; 8(2):742-8. PubMed ID: 27158366
[TBL] [Abstract][Full Text] [Related]
11. MiR-29c regulates the expression of miR-34c and miR-449a by targeting DNA methyltransferase 3a and 3b in nasopharyngeal carcinoma.
Niu M; Gao D; Wen Q; Wei P; Pan S; Shuai C; Ma H; Xiang J; Li Z; Fan S; Li G; Peng S
BMC Cancer; 2016 Mar; 16():218. PubMed ID: 26975503
[TBL] [Abstract][Full Text] [Related]
12. Tumor suppressor NGX6 inhibits the growth and metastasis of multiple cancers.
He S; Zhong Y; Shuai C; Gao D; Wei P; Li G; Peng S
Tumour Biol; 2016 May; 37(5):5751-60. PubMed ID: 26880583
[TBL] [Abstract][Full Text] [Related]
13. NGX6a is degraded through a proteasome-dependent pathway without ubiquitination mediated by ezrin, a cytoskeleton-membrane linker.
Wang L; Li X; Xiang B; Zhou M; Li X; Xiong W; Niu M; Wei P; Wang Z; Wang H; Chen P; Shen S; Peng S; Li G
J Biol Chem; 2014 Dec; 289(52):35731-42. PubMed ID: 25378401
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of UDP-glucuronosyltransferase 2B17 (UGT2B17) and dihydrofolate reductase (DHFR) genes deletion and the expression level of NGX6 mRNA in breast cancer.
Eskandari-Nasab E; Hashemi M; Rezaei H; Fazaeli A; Mashhadi MA; Moghaddam SS; Arbabi F; Jahantigh M; Taheri M
Mol Biol Rep; 2012 Dec; 39(12):10531-9. PubMed ID: 23053953
[TBL] [Abstract][Full Text] [Related]
15. Differential miRNA expression and their target genes between NGX6-positive and negative colon cancer cells.
Wang XY; Wu MH; Liu F; Li Y; Li N; Li GY; Shen SR
Mol Cell Biochem; 2010 Dec; 345(1-2):283-90. PubMed ID: 20859756
[TBL] [Abstract][Full Text] [Related]
16. NGX6 inhibits cell invasion and adhesion through suppression of Wnt/beta-catenin signal pathway in colon cancer.
Guo Q; Shen S; Liao M; Lian P; Wang X
Acta Biochim Biophys Sin (Shanghai); 2010 Jul; 42(7):450-6. PubMed ID: 20705583
[TBL] [Abstract][Full Text] [Related]
17. Signaling Transduction Network Mediated by Tumor Suppressor/Susceptibility Genes in NPC.
Wu M; Li X; Li X; Li G
Curr Genomics; 2009 Jun; 10(4):216-22. PubMed ID: 19949542
[TBL] [Abstract][Full Text] [Related]
18. Identification of a new seven-span transmembrane protein: NGX6a is downregulated in nasopharyngeal carcinoma and is associated with tumor metastasis.
Wang L; Xiang B; Yi M; Zhang WL; Yang JB; Peng SP; Li XL; Li GY
J Histochem Cytochem; 2010 Jan; 58(1):41-51. PubMed ID: 19755717
[TBL] [Abstract][Full Text] [Related]
19. Nasopharyngeal carcinoma--review of the molecular mechanisms of tumorigenesis.
Chou J; Lin YC; Kim J; You L; Xu Z; He B; Jablons DM
Head Neck; 2008 Jul; 30(7):946-63. PubMed ID: 18446839
[TBL] [Abstract][Full Text] [Related]
20. Levels of v5 and v6 CD44 splice variants in serum of patients with colorectal cancer are not correlated with pT stage, histopathological grade of malignancy and clinical features.
Zalewski B
World J Gastroenterol; 2004 Feb; 10(4):583-5. PubMed ID: 14966921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
